Michael Kinch


Michael Kinch, Associate Vice Chancellor & Director of the Center for Research Innovation & Business.
Photo by Joe Angeles/WUSTL Photos

Michael S. Kinch, Ph.D. is Associate Vice Chancellor at Washington University in St Louis, where he helps lead entrepreneurship activities as well as research on innovation in biopharmaceutical research and development. Michael founded and leads the Centers for Research Innovation in Biotechnology (CRIB) and Drug Development (CDD).

Dr. Kinch’s scientific background includes the development of medicines for cancer, immunological and infectious diseases. His current work is focused upon understanding the blend of science, medicine, business and law needed to support the development of new medicines. Prior to Washington University, he led drug discovery at Yale University as Managing Director of the Yale Center for Molecular Discovery. Dr. Kinch had served as Vice President of Research & Development and Chief Scientific Officer at Functional Genetics, Inc. in Gaithersburg, MD, where his research included investigation of Ebola, Dengue fever , pandemic influenza and other emerging infectious diseases. Preceding that, Dr. Kinch led the Departments of Cancer Biology and In Vivo Biology at MedImmune, Inc.  Prior to MedImmune, Dr. Kinch served as a tenured professor at Purdue University. Dr. Kinch was a postdoctoral fellow at the University of North Carolina at Chapel Hill, obtained a Ph.D. in Immunology from Duke University and a B.S. in Molecular Genetics from The Ohio State University. He has published more than 100 manuscripts, and been granted 15 US patents. His first book, A Prescription for Change (UNC Press, 2016), outlines a history of the biotechnology and pharmaceutical industries. Michael’s second book, Between Hope and Fear (Pegasus Books, 2018) details the history of vaccines and public reaction to these vital tools. His third book, The End of the Beginning (Pegasus, 2019) provides a history of new cancer therapies with the potential promise to eradicate this disease.    

BOOKS

A Prescription for Change

Between Hope and Fear

End of the Beginning

REPRESENTATION

Literary Agent: Don Fehr | Trident Media

Book Publicist:  Jessica Case | Pegasus Books

CONNECT

Speaker requests: Leigh Bureau

Publisher: Pegasus Books

PRESS COVERAGE of CRIB ACTIVITIES